Govt Job: for M.Pharm, M.Sc as Junior Research Fellow

The Birla Institute of Technology and Science, BITS Pilani is an all-India Institute for higher education. The primary motive of BITS is to train young men and women able and eager to create and put into action such ideas, methods, techniques and information.

The Institute is a dream come true of its founder late Mr G.D.Birla – an eminent industrialist, a participant in Indian freedom struggle and a close associate of the Father of Indian Nation late Mr. Mohandas Karamchand Gandhi.

Post : Junior Research Fellow

Applications are invited from suitable candidates for the post of Junior Research Fellow to work on a research project sponsored by DST-SERB. under the supervision of Dr. Sajeli Begum, Department of Pharmacy, BITS-Pilani, Hyderabad campus.

Title of the project : Synthesis of novel coumarin-based lignans targeting pro-inflammatory cytokines for the treatment of chronic kidney diseases

Duration of the project : 3 years

Fellowship amount : Rs. 31,000/- month

Eligibility requirements :
1. M.Pharm (Medicinal Chemistry)’ M.Sc.(Organic Chemistry) with hands-on experience in synthesis and purification techniques

2. Candidates with minimum of two-years pharmaceutical industry experience will be given preference.

3. Experience in cell culture studies and animal handling would be an added advantage.

4. In addition, good oral and written communications skills are highly desirable

Interested candidates with the above mentioned qualifications can send the application along with their CV giving detailed information about their educational qualifications, research / work experience and published research papers, if any, by 13-11-2021. to the Principal Investigator, Dr. Sajeli Begum via email : sajeli@hyderabad.bits-pilani.ac.in.

Please note that only qualified and suitable candidates will be called for the interview to be held at BITS-Pilani, Hyderabad Campus in the third week of Not/. 2021 through online mode. A selected candidate may be permitted to register for the Ph.D Programme of BITS. Pilani, subject to the fulfillment of the requirements.

Related Posts

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

NEW DELHI: Medical technology innovation is entering a new phase, with advanced cardiac implants, incisionless brain surgery, blood-based cancer screening, smart insulin delivery and real-time kidney-function monitoring among the technologies…

Three arrested after liquor bottles found at pharma firm

Patna: Three people were arrested and sent to jail after a large quantity of liquor bottles was found at Cellulas Pharma Private Limited in Kankarbagh during a raid by the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

Three arrested after liquor bottles found at pharma firm

Three arrested after liquor bottles found at pharma firm

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources